Man Group’s Pacific Biosciences PACB Stock Holding History

Man Group’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1M	Buy	+597,334	New	+$868K	﹤0.01%	1855
2025 Q4	–	Sell	-250,276	Closed	-$320K	–	2416
2025 Q3	$320K	Buy	+250,276	New	+$339K	﹤0.01%	1980
2024 Q2	–	Sell	-31,500	Closed	-$118K	–	2207
2024 Q1	$118K	Sell	31,500 -4,501	-13%	-$26.4K	﹤0.01%	2057
2023 Q4	$353K	Buy	+36,001	New	+$294K	﹤0.01%	1776
2023 Q3	–	Sell	-483,580	Closed	-$5.53M	–	572
2023 Q2	$6.43M	Buy	+483,580	New	+$5.88M	0.02%	776
2022 Q2	–	Hold	0	–	–	–	1911
2021 Q3	–	Sell	-12,711	Closed	-$444K	–	2037
2021 Q2	$444K	Sell	12,711 -149,350	-92%	-$4.34M	﹤0.01%	1595
2021 Q1	$5.4M	Sell	162,061 -91,521	-36%	-$3.2M	0.02%	651
2020 Q4	$6.58M	Buy	+253,582	New	+$4.31M	0.03%	646
2020 Q3	–	Sell	-25,315	Closed	-$87K	–	1851
2020 Q2	$87K	Buy	+25,315	New	+$86.2K	﹤0.01%	1638
2020 Q1	–	Sell	-785,846	Closed	-$4.04M	–	1817
2019 Q4	$4.04M	Sell	785,846 -516,046	-40%	-$2.62M	0.01%	1074
2019 Q3	$6.72M	Sell	1,301,892 -236,517	-15%	-$1.32M	0.03%	739
2019 Q2	$9.31M	Buy	1,538,409 +849,048	+123%	+$5.95M	0.03%	661
2019 Q1	$4.98M	Buy	+689,361	New	+$4.99M	0.02%	925

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Man Group's PACB Position: Q2 2026 in Review

Man Group opened a new position in Pacific Biosciences (PACB) in Q2 2026: 597,334 shares worth $1M. The stake represents ﹤0.01% of the portfolio and ranks #1855 among its holdings. This is a return to the name: Man Group previously reported a position in PACB as recently as Q3 2025.

Man Group first reported a position in PACB in Q1 2019 and has held it in 13 quarters since. The position peaked at $9.31M in Q2 2019. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Man Group held 597,334 shares of Pacific Biosciences worth $1M as of Q2 2026.
Pacific Biosciences was a new Man Group position in Q2 2026.
Pacific Biosciences made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1855 holding.
Man Group first reported a position in Pacific Biosciences in Q1 2019 and has held it in 13 quarters since.
Man Group's Pacific Biosciences position peaked at $9.31M in Q2 2019.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.